Back to Journals » Drug Design, Development and Therapy » Volume 9

Original Research

Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer

       
Total article views   HTML views PDF downloads Totals
11,779 Dovepress* 10,139+ 1,809 11,948
PubMed Central* 1,640 446 2,086
Totals 11,779 2,255 14,034
*Since 8 June 2015
+Since July 2016

View citations on PubMed and Google Scholar